S95011

· Institut de Recherches Internationales Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S95011, covering 2024-04-23 to 2024-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients [Phase 2]